Scientists probe immune cells to unravel chronic GVHD mystery
NCT ID NCT07235501
First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 4 times
Summary
This study looks at why some people develop chronic graft-versus-host disease (GVHD) after a stem cell transplant. Researchers will collect blood, stool, saliva, and tissue samples from 75 participants to track immune cell changes over time. The goal is to better understand the disease, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a liquid form of a Graft-Versus-Host disease drug be as effective as the pill?
- A smartphone app may help young cancer survivors get fitter — a trial puts it to the test
- Texting your symptoms: a digital coach for cancer side effects?
- Can a cancer drug tame graft-versus-host disease when steroids fail?
- Faith and mindfulness join forces to heal black cancer survivors
- Scientists map immune battlefield in chronic GVHD tissue